Figures computed from official regulatory filings — .
Analysttarget 153.06 USD (+177%) · consensus 4.89/5 · 9 buy · 0 hold · 0 sell
Ownershipinsiders 11.94% · institutions 94.95% · short 11.6% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for BRIGHT MINDS BIOSCIENCES INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Market information source · Oct 19, 2026
SEC company identity · Oct 19, 2026
Open-market timeline · full history
12 buys1 sell— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Cormorant Asset Management, LPtrack record | Sell | $9.8M | SEC |
| Cormorant Asset Management, LPtrack record | Buy | $4M | conv 33 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $374K | conv 24 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $78.4K | conv 20 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $22.9K | conv 20 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $214.1K | conv 22 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $25K | conv 20 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $1.1M | conv 37 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $65.1K | conv 21 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $171.8K | conv 20 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $922.8K | conv 21 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $56.9K | conv 20 | SEC |
| Cormorant Global Healthcare Master Fund, LPtrack record | Buy | $224.7K | conv 21 | SEC |